To do this, wild-type recipient mice were s.c. injected with B16-MO5 melanoma cells, then OVA257-264-stimulated wild-type or SKAP55 KO CD8+ CTLs were i.v. injected into these recipient mice at day 8. Here, CD8A is linked to melanoma.